As of 2026-04-03, the EV/EBITDA ratio of Middle East Healthcare Company PJSC (4009.SR) is 7.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4009.SR's latest enterprise value is 5,801.26 mil SAR. 4009.SR's TTM EBITDA according to its financial statements is 787.62 mil SAR. Dividing these 2 quantities gives us the above 4009.SR EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 14.4x | 13.7x |
| Forward P/E multiples | 9.8x - 12.9x | 11.5x |
| Fair Price | 78.19 - 111.79 | 93.19 |
| Upside | 119.1% - 213.3% | 161.2% |
| Date | EV/EBITDA |
| 2026-04-02 | 7.37 |
| 2026-04-01 | 7.40 |
| 2026-03-31 | 7.25 |
| 2026-03-30 | 7.25 |
| 2026-03-29 | 7.20 |
| 2026-03-26 | 7.28 |
| 2026-03-25 | 7.25 |
| 2026-03-24 | 7.16 |
| 2026-03-16 | 7.16 |
| 2026-03-15 | 6.97 |
| 2026-03-12 | 6.96 |
| 2026-03-11 | 6.88 |
| 2026-03-10 | 6.91 |
| 2026-03-09 | 6.83 |
| 2026-03-08 | 6.94 |
| 2026-03-05 | 6.83 |
| 2026-03-04 | 6.80 |
| 2026-03-03 | 6.61 |
| 2026-03-02 | 6.58 |
| 2026-03-01 | 6.70 |
| 2026-02-26 | 6.89 |
| 2026-02-25 | 6.97 |
| 2026-02-24 | 7.01 |
| 2026-02-23 | 7.06 |
| 2026-02-19 | 7.08 |
| 2026-02-18 | 7.18 |
| 2026-02-17 | 7.23 |
| 2026-02-16 | 7.32 |
| 2026-02-15 | 7.41 |
| 2026-02-12 | 7.37 |
| 2026-02-11 | 7.29 |
| 2026-02-10 | 7.23 |
| 2026-02-09 | 7.17 |
| 2026-02-08 | 7.14 |
| 2026-02-05 | 7.17 |
| 2026-02-04 | 7.33 |
| 2026-02-03 | 7.40 |
| 2026-02-02 | 7.34 |
| 2026-02-01 | 7.34 |
| 2026-01-29 | 7.35 |
| 2026-01-28 | 7.45 |
| 2026-01-27 | 7.42 |
| 2026-01-26 | 7.45 |
| 2026-01-25 | 7.49 |
| 2026-01-22 | 7.44 |
| 2026-01-21 | 7.05 |
| 2026-01-20 | 7.04 |
| 2026-01-19 | 7.08 |
| 2026-01-18 | 7.08 |
| 2026-01-15 | 7.03 |